Creating a hub to boost life sciences and diversity in Baltimore
Official title: University of Maryland BaltImore Life Science Discovery (UM-BILD) Accelerator
Funded at University of Maryland Baltimore · NIH-10932923 · Data updated 2026-11-12
This study is all about creating a new program to help people in West Baltimore and Greater Baltimore learn about jobs in life sciences and entrepreneurship, especially focusing on supporting underrepresented minorities to boost their skills and opportunities in these fields.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 25, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $997,036 |
| NIH project number | 5U01GM152511-02 |
| Project ID | NIH-10932923 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include underrepresented minorities interested in pursuing careers in biomedical sciences or entrepreneurship.
✕Less likely to help
Patients who do not identify as underrepresented minorities or who are not interested in careers in the biomedical field may not receive direct benefits from this research.
What this research studies
The University of Maryland BaltImore Life Science Discovery Accelerator (UM-BILD) aims to establish a new program that enhances the life science economy in West Baltimore and Greater Baltimore. This initiative focuses on training a diverse workforce in biomedical and entrepreneurial fields, particularly targeting underrepresented minorities. By partnering with various universities and institutions, UM-BILD will provide access to resources, expertise, and networking opportunities to foster innovation and growth in the life sciences sector. The program seeks to address the disparity in representation within the biomedical workforce and promote economic development in the region.
Why it matters
Potential benefit: If successful, this research could significantly enhance workforce diversity in the biomedical field, leading to improved innovation and economic growth in the life sciences sector.
How similar studies have gone: Other initiatives aimed at increasing diversity in the biomedical workforce have shown success, indicating that this approach has the potential for positive outcomes.
Where this research is happening
-
University of Maryland Baltimore
Baltimore, United States Active
Researchers
- Principal investigator: Rose, Jason J — University of Maryland Baltimore
- Study coordinator: Rose, Jason J
Related research
Other NIH-funded projects on the same topics.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
NPRL2 loss and focal cortical dysplasia in epilepsy
This grant investigates how losing NPRL2 in the brain contributes to focal cortical dysplasia and epilepsy in children.
-
New way to make head and neck cancer treatments work better
A research project at the University of Maryland Baltimore aims to improve treatment for advanced head and neck cancer, with a focus on making cisplatin and newer therapies work better while reducing kidney side effects.
-
Genetics and function of inherited brain disorders that affect thinking and behavior
Scientists are studying how genes and cellular helpers shape brain development and why certain kids have intellectual disabilities and adaptive-behavior challenges.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.